Midazolam: Difference between revisions
(duration) |
Andrew.mason (talk | contribs) (Added pediatric dosing) |
||
| Line 16: | Line 16: | ||
==Pediatric Dosing== | ==Pediatric Dosing== | ||
''See [[critical care quick reference]] for drug doses by weight.'' | ''See [[critical care quick reference]] for drug doses by weight.'' | ||
*Anxiolysis/sedation: | |||
**6mo-5yr: 0.05-0.1 mg/kg IV push | |||
**6-12yr: 0.025-0.05 mg/kg IV push | |||
*Intranasal | |||
**Seizure: 0.2 mg/kg IN divided between nostrils | |||
**Procedural sedation: 0.2-0.6 mg/kg IN divided between nostrils | |||
==Special Populations== | ==Special Populations== | ||
*[[Drug Ratings in Pregnancy|Pregnancy Rating]]: D | *[[Drug Ratings in Pregnancy|Pregnancy Rating]]: D | ||
**Maternal use shortly before delivery associated with floppy infant syndrome | **Maternal use shortly before delivery associated with floppy infant syndrome | ||
*Lactation: Distributed in breast milk, use with caution | *Lactation: Distributed in breast milk, use with caution | ||
*Renal Dosing: | *Renal Dosing: | ||
**Adult | **Adult: Decrease by 50% for severe renal failure | ||
**Pediatric | **Pediatric | ||
*Hepatic Dosing: | *Hepatic Dosing: | ||
**Adult | **Adult: Prolonged clearance in cirrhosis | ||
**Pediatric | **Pediatric | ||
Revision as of 05:13, 22 November 2016
See critical care quick reference for drug doses by weight.
General
- Type: Benzodiazepines
- Dosage Forms: IV
- Common Trade Names: Versed
Adult Dosing
- Anxiolysis/sedation:
- 1-2mg IV push
- 0.07 to 0.08 mg/kg IM, usual dose 5 mg for 60 kg pt
- ICU Sedation:
- Load: 10-50mcg/kg IV infusion
- Maintenance: 20-100 mcg/kg/hr infusion
- Use with standardized sedation protocol for titration
Pediatric Dosing
See critical care quick reference for drug doses by weight.
- Anxiolysis/sedation:
- 6mo-5yr: 0.05-0.1 mg/kg IV push
- 6-12yr: 0.025-0.05 mg/kg IV push
- Intranasal
- Seizure: 0.2 mg/kg IN divided between nostrils
- Procedural sedation: 0.2-0.6 mg/kg IN divided between nostrils
Special Populations
- Pregnancy Rating: D
- Maternal use shortly before delivery associated with floppy infant syndrome
- Lactation: Distributed in breast milk, use with caution
- Renal Dosing:
- Adult: Decrease by 50% for severe renal failure
- Pediatric
- Hepatic Dosing:
- Adult: Prolonged clearance in cirrhosis
- Pediatric
Contraindications
- Allergy to class/drug
Adverse Reactions
Serious
- Apnea
- Hypopnea
- Hypotension
- Delirium, when used for prolonged periods in ICU setting
Common
- Drowsiness
- Nausea/vomiting
Pharmacology
- Peak effect:
- IM: Children: 15 to 30 minutes; Adults: 30 to 60 minutes
- IV: 5 to 7 minutes
- Intranasal: 10 minutes
- Duration
- IV: Single dose: <2 hours (dose-dependent),up to 6 hours w/ cirrhosis
- IM: Up to 6 hours; Mean: 2 hours
- Intranasal: Children: 18 to 41 minutes
- Half-life: 1.8-6.4 hr
- Metabolism: Metabolized in liver by CYP3A4 to active metabolite alpha1-hydroxymidazolam
- Excretion: Renal
- Mechanism of Action: CNS depressant. Acts at GABA receptor to increase frequency of chloride channel opening, causing hyperpolarization and stabilization of neuronal membrane.
See Also
References
Micromedex